NVCR

10.7100.19%
CB

Christoph Brackmann

Chief Financial Officer

Mr. Christoph Brackmann serves as Chief Financial Officer of NovoCure Limited since January 1, 2025. Mr. Brackmann served as Interim Head of Investor Relations at Shire plc. Mr. Brackmann served at Moderna Inc. where he served as Senior Vice President of Finance since 2019. While at Moderna he established and built the finance team and oversaw the rapid expansion of the organization during the COVID-19 pandemic. During his career at Moderna, Mr. Brackmann, 51, oversaw the expansion and development of the Finance function, including Financial Planning and Analysis, Accounting, Tax, Treasury, Procurement and Business Services. Prior to Moderna, Mr. Brackmann served as the Vice President of Investor Relations and Head of International Finance at Shire plc (acquired by Takeda) and in various financial roles at Eli Lilly and Company and Novartis. Mr. Brackmann earned his Master of Business Administration from the SDA Bocconi School of Management, Milan in 2003 and holds a bachelor’s degree in Business and Economics from the University of Mannheim.

Positions